Clinician-context pageThis topic can involve test or imaging interpretation, neurological disease, surgery, medication, or complex underlying conditions. BioConst keeps this page as an explainer, not a decision guide.
What this means
Osteogenesis imperfecta is a heritable fragility disorder, often involving type I collagen biology. Fractures cannot be reduced to calcium intake.[1]
What people may notice
- People can have fractures with minimal or absent trauma, variable dentinogenesis imperfecta, and hearing loss in some forms.[1]
- Severity varies widely, so mild and severe cases should not be read as one pattern.[1]
- In children, fracture interpretation requires pediatric and genetic context.[2]
Key variables
Z-scorePediatric densitometry cannot diagnose osteoporosis by itself.[2]
BMDBMD can contribute to skeletal assessment but does not capture collagen quality alone.[1]
Why it happens
- Many cases involve COL1A1 or COL1A2 variants affecting type I collagen.[1]
- Other genetic forms exist, so a single collagen story does not cover every case.[1]
- Fragility comes from matrix quality, skeletal development, and fracture mechanics, not just density.[1]
Clinical response directions
- Clinical teams may coordinate genetics, orthopedics, rehabilitation, dental/hearing care, fracture care, and selected medication classes.[1]
- Mobility, pain, fracture prevention, and family counseling are often part of the care context.[1]
- BioConst does not interpret genetic tests or pediatric fracture histories.[1,2]
Common traps
- Do not explain hereditary brittle bone as a calcium shortage.[1]
- Do not diagnose a child from DXA alone.[2]
- Normal BMD does not exclude matrix-quality problems.[1]